NovAccess Global Inc. reported its financial results for the fiscal year ended September 30, 2024. The company generated no revenue or cost of goods sold for the period. Research and development expenses were reported at USD 153.9 thousand. Other expenses amounted to USD 1.8 million for the fiscal year, reflecting a decrease primarily due to a reduction in loss on derivative liabilities and lower interest expense, partially offset by a legal provision, an impairment charge, and increased expenses related to a price guarantee on shares issued as a commitment fee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovAccess Global Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-000158), on January 14, 2026, and is solely responsible for the information contained therein.